Fenofibrate-Associated Nephrotoxicity Common in Patients With Gout
Researchers assessed the incidence and potential risk factors for the development of
fenofibrate-associated nephrotoxicity in patients with gout.
Sheila Jacobs
Contributing Writer
Sheila Jacobs is the president of STJ Editorial Services. For more than 25 years, Sheila has been providing writing, fact-checking, and editorial services to numerous clients in the medical education, promotional, and managed care arenas, from the conceptual stage through completion of the final editorial product. Her focus has been in a diverse array of therapeutic areas.
